This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Jan;25(1):19-21.

doi: 10.1016/s0145-2126(00)00100-4.

Best supportive care for the anaemia of myelodysplasia: inclusion of recombinant erythropoietin therapy?

D T Bowen¹, E Hellstrom-Lindberg

Affiliations

PMID: 11137556
DOI: 10.1016/s0145-2126(00)00100-4

Comment

Best supportive care for the anaemia of myelodysplasia: inclusion of recombinant erythropoietin therapy?

D T Bowen et al. Leuk Res. 2001 Jan.

. 2001 Jan;25(1):19-21.

doi: 10.1016/s0145-2126(00)00100-4.

Authors

D T Bowen¹, E Hellstrom-Lindberg

Affiliation

¹ Molecular and Cellular Pathology, Ninewells Hospital, University of Dundee, DD1 9SY, Dundee, UK.

PMID: 11137556
DOI: 10.1016/s0145-2126(00)00100-4

No abstract available

PubMed Disclaimer

Comment on

Long-term follow-up of 18 patients with myelodysplastic syndromes responding to recombinant erythropoietin treatment.
Hast R, Wallvik J, Folin A, Bernell P, Stenke L. Hast R, et al. Leuk Res. 2001 Jan;25(1):13-18. doi: 10.1016/s0145-2126(00)00073-4. Leuk Res. 2001. PMID: 11137555 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science